Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Complement C3 Convertases"'
Autor:
Gregory LaRosa, Hua Zhou, Edward So, Henrik S. Olsen, Denis Rybin, David S. Block, Xiaoyu Zhang, Jane Owens, Emmanuel Y. Mérigeon, Scott E. Strome
Publikováno v:
Blood Advances. 1:504-515
GL-2045 is a recombinant human immunoglobulin G1 (IgG1)-based Fc multimer designed to recapitulate the anti-inflammatory activities of intravenous immunoglobulin (IVIG) on the innate and adaptive immune responses. We used functional in vitro studies
Autor:
Petter Storm, Erik Renström, Ben C. King, Petter Vikman, Emilia Ottosson-Laakso, Anna M. Blom, Vini Nagaraj
Publikováno v:
Biochemical and Biophysical Research Communications; 460(3), pp 518-524 (2015)
CD55 is a glycosylphosphatidylinositol-anchored protein, which inhibits complement activation by acting on the complement C3 convertases. CD55 is widely localized in the cholesterol rich regions of the cell plasma membrane termed membrane rafts. CD55
Autor:
Thomas Hunziker, Reinhard Burger, Hans U. Lutz, Emiliana Jelezarova, Ralph M. Trüeb, Stammler P, Valentina Bianchi, Peter J. Späth
Publikováno v:
Blood. 103:465-472
Intravenously applied normal human immunoglobulin G (IgG) has anti-inflammatory effects in the treatment of autoimmune diseases. Systemic inflammation can originate from an overreacting amplification loop of the complement system. In blood, C3b2-cont
Autor:
Lynne M. Mitchell, Nasima Muqim, M. Edward Medof, Megan P. Dybvig, John P. Atkinson, Lisa Kuttner-Kondo, Dennis E. Hourcade
Publikováno v:
Journal of Biological Chemistry. 278:52386-52391
The cleavage of C3 by the C3 convertases (C3bBb and C4b2a) determines whether complement activation proceeds. Dissociation (decay acceleration) of these central enzymes by the regulators decay-accelerating factor (DAF), complement receptor 1 (CR1), f
Autor:
V. M. Holers, Dennis E. Hourcade, Youn-Uck Kim, L. M. Wagner, T. Seya, Taroh Kinoshita, H. Molina
Publikováno v:
The Journal of Experimental Medicine
Normal host cells are protected from the destructive action of complement by cell surface complement regulatory proteins. In humans, decay-accelerating factor (DAF) and membrane cofactor protein (MCP) play such a biologic role by inhibiting C3 and C5
Autor:
Selina Stippa, Jörg Köhl, Peter F. Zipfel, Martin Oppermann, Christine Skerka, Lars G. Fritsche, Bernhard H. F. Weber, Manoj K. Pandey, Andrea Hartmann, Claudia N. Keilhauer, Nadine Lauer
Publikováno v:
Human molecular genetics. 19(23)
A frequent deletion of complement factor H (CFH)-related genes CFHR3 and CFHR1 (ΔCFHR3/CFHR1) is considered to have a protective effect against age-related macular degeneration (AMD), although the underlying mechanism remains elusive. The deletion s
Publikováno v:
Journal of Infectious Diseases. 166:1245-1250
A major protein secreted by vaccinia virus-infected cells has structural similarity to the super-family of complement-control proteins. This vaccinia complement-control protein (VCP) was studied to determine how it regulates complement activation. VC
Autor:
A. Scheffler, Wolfgang Ertel, Philip F. Stahel, V. M. Holers, Amir M. Hossini, C. E. Heyde, Iris Leinhase, Oliver I. Schmidt
Publikováno v:
Chirurgisches Forum 2005 ISBN: 3540248889
122. Kongress der Deutschen Gesellschaft für Chirurgie; 20050405-20050408; München; DOC05dgch2629 /20050615/
122. Kongress der Deutschen Gesellschaft für Chirurgie; 20050405-20050408; München; DOC05dgch2629 /20050615/
Activation of complement plays a central role in the pathogenesis of neuroinflammation leading to secondary brain injury following a traumatic insult to the brain. In a previous study, we were able to show improved neurological recovery in brain-inju
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1be05516988177f94d406f90beabf1d
https://doi.org/10.1007/3-540-26560-0_117
https://doi.org/10.1007/3-540-26560-0_117
Autor:
Shannon Fishman, Rajeev G. Kallanthottathil, Andrew Sprague, James Butler, Muthiah Manoharan, Satya Kuchimanchi, Kevin Fitzgerald, Akshay Vaishnaw, Anna Borodovsky, Kristina Yucius, Tuyen Nguyen, Martin Maier, Rachel Meyers
Publikováno v:
Blood. 122:2471-2471
The complement system is a pivotal player in multiple hematological conditions. Antibody blockade of the C5 component of complement has been approved as a treatment for both paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic-uremic synd
Publikováno v:
The Journal of Experimental Medicine
In this study the physiological role of properdin and the differential subunit composition of the solid phase enzymes of the pathway have been explored. Cell-bound C3 and C5 convertase differ in their C3b requirement. Apparently one molecule of C3b i